These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1012194)

  • 21. [Action of a taurine-nucleotide-vitamin association on carbohydrate metabolism].
    De Lorenzi F
    Clin Ter; 1971 Jun; 57(5):441-70. PubMed ID: 5113575
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical considerations on the therapeutic action of Nucleodoxine].
    Idéo G
    Omnia Med Ther; 1968; 46(2):409-15. PubMed ID: 5739611
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of treatment with oral citrate and pyridoxine in patients with primary hyperoxaluria type 1].
    Castelló Girona F; Riudor Taravilla E; Enríquez Civicos G; Güell Torné C; Fornaguera Soler F
    An Esp Pediatr; 1999 Apr; 50(4):397-401. PubMed ID: 10356835
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recent acquisitions on the pathogenesis of hyperammoniemia: clinico-experimental study on a new anti-ammonia drug].
    Furiosi P; Mercati U; Pasquini F
    Minerva Med; 1967 Feb; 58(15):553-63. PubMed ID: 6021622
    [No Abstract]   [Full Text] [Related]  

  • 25. [Research on the value of a taurine, nucleotide and vitamin combination in neurologic diseases].
    Brogi L; Avesani A
    Clin Ter; 1974 Aug; 70(4):357-78. PubMed ID: 4426172
    [No Abstract]   [Full Text] [Related]  

  • 26. Observations with Magurlit in the treatment of patients with uric acid stone.
    Rosdy E; Kiss T; Török P
    Ther Hung; 1984; 32(2):82-4. PubMed ID: 6546266
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use in geriatrics of an association of taurine, nucleotides and vitamins].
    Calabrese L; Montagnani I
    Clin Ter; 1970 Mar; 52(5):451-9. PubMed ID: 5421986
    [No Abstract]   [Full Text] [Related]  

  • 28. Prophylaxis of oxalate urolithiasis with alkaline citrates.
    Frang D; Berényi M; Szebeni R
    Ther Hung; 1990; 38(2):64-70. PubMed ID: 2377983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of taurine-nucleotide-vitamin compound on experimental hypercholesteremia and on some forms of human arteriosclerosis].
    Piazza V
    Omnia Med Ther; 1966; 4(2):513-20. PubMed ID: 5962153
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nosology and therapy of hyperammonemia in liver diseases].
    Reinelt D; Schmidt P; Weinhold D
    Z Gesamte Inn Med; 1969 Aug; 24(15):480-3. PubMed ID: 5363188
    [No Abstract]   [Full Text] [Related]  

  • 31. The therapy of hyperammonemia due to ornithine transcarbamylase defiency in a male neonate.
    Snyderman SE; Sansaricq C; Phansalkar SV; Schacht RC; Norton PM
    Pediatrics; 1975 Jul; 56(1):65-73. PubMed ID: 1153252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nucleodoxin in the treatment of alcoholic myocardiopathies. Hemodynamic evaluations with the polygraphic method].
    Forattini C
    Omnia Med Ther; 1970; 48(3):361-73. PubMed ID: 5513564
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood ammonia levels in portal hypertension and in liver diseases in children].
    Michalowicz-Wojczyńska E
    Pediatr Pol; 1968; 44(1):7-15. PubMed ID: 5728848
    [No Abstract]   [Full Text] [Related]  

  • 34. [Behavior of blood ammonia in liver patients treated with arginine-glucose-1-phosphate].
    Novelli E; Pinacci U
    Z Gesamte Inn Med; 1967 Nov; 22(22):704-9. PubMed ID: 5623736
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of hyperlactacidemia in cirrhotic patients with pyridoxine-alpha-ketoglutarate (PAK).
    Belvisi A; Matergi M; Fici F
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):142-6. PubMed ID: 7068288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic activity, evaluated by hepatoparenchymal clearence with indocyanine green, of a "taurine-nucleotide-vitamin" drug association in hepatic steatosis].
    Proto C; Grasso G; Levi GF
    Omnia Med Ther; 1967; 45(4):857-63. PubMed ID: 5605420
    [No Abstract]   [Full Text] [Related]  

  • 37. Elimination of cardiac arrhythmias using oral taurine with l-arginine with case histories: Hypothesis for nitric oxide stabilization of the sinus node.
    Eby G; Halcomb WW
    Med Hypotheses; 2006; 67(5):1200-4. PubMed ID: 16797868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic effect of a combination product (taurine-nucleotides-vitamins) in the course of detoxication of psychiatric alcoholic patients].
    Dogliani P; Senini G; Bertuzzi F; Gherardi S
    Omnia Med Ther; 1970; 48(1):165-74. PubMed ID: 5488123
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of taurine supplements on growth, fat absorption and bile acid on cystic fibrosis.
    Carrasco S; Codoceo R; Prieto G; Lama R; Polanco I
    Acta Univ Carol Med (Praha); 1990; 36(1-4):152-6. PubMed ID: 2130680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with reduced functional liver mass.
    Lee JH; Kim WH; Cho H; Kwak YS; Kim S; Paik WK
    Biochem Biophys Res Commun; 1998 Jul; 248(2):391-4. PubMed ID: 9675147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.